Humanigen CEO Receives PharmaVOICE 100 Red Jacket Award
August 11, 2017 08:00 ET
|
Humanigen, Inc.
BRISBANE, Calif., Aug. 11, 2017 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today...
Humanigen Announces Completion of Benznidazole Bioavailability Study
August 08, 2017 08:00 ET
|
Humanigen, Inc.
BRISBANE, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today...
Humanigen, Inc. Is Effective Today
August 07, 2017 07:00 ET
|
Humanigen, Inc.
BRISBANE, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today...
KaloBios To Change Company Name To Humanigen, Inc.
July 27, 2017 16:37 ET
|
KaloBios Pharmaceuticals Inc.
Transforming company with focus and commitment on neglected and rare diseases Continue to expect New Drug Application (NDA) submission for benznidazole in Chagas disease to FDA in first quarter 2018 ...
KaloBios Receives $5.0M in New Funding Commitment From Existing Investors
July 12, 2017 16:10 ET
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., July 12, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTCQB:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios Receives Orphan Drug Designation for Benznidazole in the Treatment of Chagas Disease
July 11, 2017 17:36 ET
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., July 11, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTCQB:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
Benznidazole IND for Chagas Disease Receives Clearance by FDA
June 27, 2017 08:00 ET
|
KaloBios Pharmaceuticals Inc.
Open IND is a significant step to advancing the benznidazole development programCompany remains on track to submit a New Drug Application in the first quarter of 2018 BRISBANE, Calif., June 27,...
KaloBios Upgrades Stock to OTCQB Market
June 26, 2017 07:00 ET
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., June 26, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTCQB: KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios CEO to Present at Two Upcoming Investor Conferences
May 31, 2017 08:00 ET
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios Submits IND Application for Benznidazole to FDA
May 30, 2017 08:00 ET
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., May 30, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...